Bionet (1784)

Currency in TWD
66.70
-0.30(-0.45%)
Closed·
1784 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
66.2067.20
52 wk Range
63.40118.00
Key Statistics
Bid/Ask
37.10 / 37.20
Prev. Close
84.2
Open
67
Day's Range
66.2-67.2
52 wk Range
63.4-118
Volume
198.73K
Average Volume (3m)
215.11K
1-Year Change
-5.5241%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1784 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 14, 2026
EPS / Forecast
0,25 / 0,29
Revenue / Forecast
314,7M / 302M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.97%
Dividend Yield
1.30%
Industry Median 0.35%
Annualised payout
0.87
Paid annually
5-Years Growth
+38.93%
Growth Streak

1784 Income Statement

Compare 1784 to Peers and Sector

Metrics to compare
1784
Peers
Sector
Relationship
P/E Ratio
69.1x15.3x−0.4x
PEG Ratio
−1.93−0.290.00
Price/Book
2.7x1.2x2.6x
Price / LTM Sales
2.7x3.6x3.0x
Upside (Analyst Target)
-31.5%58.4%
Fair Value Upside
Unlock24.9%8.6%Unlock

BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin care products. It also provides storage and application of hematopoietic stem cells, analytical testing, clinical and preclinical research, commercialized cell-derived products, and Exosome, a cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
38,00K0,08%2,53M
Other Institutional Investors
8,51M16,91%567,35M
Public Companies & Retail Investors
41,76M83,02%2,79B
Total
50,31M100,00%3,36B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Genetics Generation Advancement Corp.5,96%2 999 869200 091
Henglian Investment Co., Ltd.3,48%1 753 065116 929

FAQ

What Is the Bionet (1784) Stock Price Today?

The Bionet stock price today is 66,70 TWD.

What Stock Exchange Does Bionet Trade On?

Bionet is listed and trades on the Taipei Exchange.

What Is the Stock Symbol for Bionet?

The stock symbol for Bionet is "1784."

Does Bionet Pay Dividends? What’s The Current Dividend Yield?

The Bionet dividend yield is 1.3%.

What Is the Bionet Market Cap?

As of today, Bionet market cap is 3,37B TWD.

What Is Bionet's Earnings Per Share (TTM)?

The Bionet EPS (TTM) is 0,97.

When Is the Next Bionet Earnings Date?

Bionet will release its next earnings report on Aug 19, 2026.

From a Technical Analysis Perspective, Is 1784 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Bionet Stock Split?

Bionet has split 5 times.

What is the current trading status of Bionet (1784)?

As of Jun 23, 2026, Bionet (1784) is trading at a price of 66,70 TWD, with a previous close of 84,20 TWD. The stock has fluctuated within a day range of 66,20 TWD to 67,20 TWD, while its 52-week range spans from 63,40 TWD to 118,00 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.